8251 - 8275 of 9145 Results
Title
Year
-
OPENTitle: Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panelJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 9Issue #: 1Start Page: e12375End Page: e12375Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12375Best OA location URL: https://escholarship.org/uc/item/12q8s9x7Citation Count: 14
-
OPENTitle: Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regionsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 132Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci149904Best OA location URL: http://www.jci.org/articles/view/149904/files/pdfCitation Count: 35
-
OPENTitle: State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 9Issue #: 1Start Page: e12376End Page: e12376Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12376Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12376Citation Count: 16
-
OPENTitle: Editorial: Brain stimulation in cognition and diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page: 1213272End Page: 1213272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1213272Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1213272/pdfCitation Count: 0
- Functional Connectivity of Vermis Correlates with Future Gait Impairments in Parkinson's Disease2021OPENTitle: Functional Connectivity of Vermis Correlates with Future Gait Impairments in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2559End Page: 2568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28684Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8595492Citation Count: 29
-
OPENTitle: Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 1Start Page: e026901End Page: e026901Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.122.026901Best OA location URL: https://escholarship.org/uc/item/3128823zCitation Count: 18
- Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease2021OPENTitle: Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 334End Page: 342Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28850Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8922308Citation Count: 42
- Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers2021OPENTitle: Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 629End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940604Citation Count: 8
-
OPENTitle: Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 264End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28837Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8840955Citation Count: 27
-
OPENTitle: Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page: S32End Page: S35Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13538Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13538Citation Count: 5
-
OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355084Citation Count: 7
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8192481Citation Count: 15
-
OPENTitle: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 596End Page: 605Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13678Best OA location URL: https://escholarship.org/uc/item/2wb861ndCitation Count: 2
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: https://eprints.ncl.ac.uk/275504Citation Count: 45
- Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma2020OPENTitle: Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head traumaJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 150Issue #:Start Page: 105237End Page: 105237Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105237Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996120305131?via%3DihubCitation Count: 33
-
OPENTitle: Self-Image in Women with Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 3Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230017Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230017?id=journal-of-parkinsons-disease%2Fjpd230017Citation Count: 11
-
OPENTitle: Early‐Onset Neurodevelopmental Movement Disorder Secondary to Novel Mutation in KCNN2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page: S9End Page: S12Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13535Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9464988Citation Count: 4
-
OPENTitle: Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient miceJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page: 10End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-2-10Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-2-10Citation Count: 72
-
OPENTitle: Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 55Issue #: 11Start Page: 8592End Page: 8601Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-0977-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6677544Citation Count: 93
-
OPENTitle: Analysis of COQ2gene in multiple system atrophyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-9-44Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-9-44Citation Count: 47
-
OPENTitle: The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activityJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 32End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0174-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0174-zCitation Count: 82
-
OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 186
-
OPENTitle: miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)Journal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 55End Page: 55Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0121-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0121-4Citation Count: 162
-
RESTRICTEDTitle: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP BiosensorJournal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 3Start Page: 585End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/mol.108.048884Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3766527Citation Count: 152
-
OPENTitle: Keystroke-Dynamics for Parkinson's Disease Signs Detection in an At-Home Uncontrolled Population: A New Benchmark and MethodJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 70Issue #: 1Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tbme.2022.3187309Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9904385Citation Count: 32